Search for: "NOVARTIS PHARMACEUTICALS CORPORATION " Results 81 - 100 of 219
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2013, 12:45 am by Shamnad Basheer
 I'd like to think that, as with the Novartis Supreme Court submission, I follow a strict issue based approach. [read post]
30 Dec 2012, 3:30 am by Gene Quinn & Angel Krippner
On October 31, 2012, Acacia Research Corporation (Nasdaq:ACTG) announced that its subsidiaries... [read post]
20 Nov 2012, 9:49 am by fraudfighters
The Texas Attorney General’s Office announced a $19.9 million settlement it reached with international pharmaceutical company, Novartis Pharmaceutical Corporation. [read post]
1 Aug 2012, 7:04 pm
In this case, Novartis Pharmaceuticals Corporation sales representatives in 2006 claim that they were denied overtime pay which is a violation of the Fair Labor Standards Act. [read post]
18 Jun 2012, 1:38 pm
SmithKline Beecham Corporation that pharmaceutical sales representatives are not entitled to overtime pay under the Fair Labor Standards Act, as reported by the Wall Street Journal. [read post]
13 Jun 2012, 7:24 am by Steven Berk
Eckard received an award of $96 million – an astounding number that was widely criticized by corporate interests at the time. [read post]
7 Jun 2012, 11:52 am
Consumer safety advocacy groups maintain that packages of Clear Care contact lens cleaner, a product manufactured by multinational pharmaceutical conglomerate Novartis, don’t carry a strong enough caution that the 3 percent hydrogen peroxide solution shouldn’t be used directly in the eyes, or clear enough warnings that it must be used only with the product’s proprietary case that neutralizes the solution. [read post]
8 May 2012, 6:42 am
 Pharmaceuticals corporation Novartis has recently settled a class action lawsuit brought by current and former sales representatives for $99 million dollars. [read post]
16 Apr 2012, 2:15 pm by Leland E. Beck
Core FLSA Facts: Tom Goldstein, Goldstein & Russell, P.C., for the petitioner, succinctly laid out the factual problem posed by pharmaceutical sales in these cases: [J]ust to frame this industry, the pharmaceutical company sells its products; it sells them to pharmaceutical wholesalers, which sell them to pharmacies … which sell them to customers, which have a relationship with a doctor, who may or may not have met with a detailer [i.e. the subject of the suit].… [read post]
29 Mar 2012, 10:00 pm by Stephanie Figueroa
Prometheus. 3) Intellectual Property Watch: Novartis India Challenge Postponed To July – This post shares how the Indian Supreme Court today postponed hearing the high-profile case involving Swiss pharmaceutical producer Novartis’ challenge of India’s patent law until July. 4) Patents Post-Grant: AIA Changes to Greatly Increase Stays of District Court Actions – This post discusses the estoppel provisions of Post Grant Review and Inter… [read post]
29 Mar 2012, 10:00 pm by Stephanie Figueroa
Prometheus. 3) Intellectual Property Watch: Novartis India Challenge Postponed To July – This post shares how the Indian Supreme Court today postponed hearing the high-profile case involving Swiss pharmaceutical producer Novartis’ challenge of India’s patent law until July. 4) Patents Post-Grant: AIA Changes to Greatly Increase Stays of District Court Actions – This post discusses the estoppel provisions of Post Grant Review and Inter… [read post]
20 Mar 2012, 7:55 am
In support, Novartis relied upon its earlier registered CTM ZIMBUS (2 356 954) in Class 5 for ‘pharmaceutical preparations’. [read post]
12 Mar 2012, 5:41 pm by FDABlog HPM
Novartis Pharmaceuticals Corp., No. 33-av-00001 (D.N.J., Mar. 7, 2012) (Complaint) Plumbers and Pipefitters Local 572 Health and Welfare Fund v. [read post]
6 Mar 2012, 6:17 am
Earlier this year, Novartis Pharmaceuticals Corporation agreed to a $99 million settlement of a class action overtime lawsuit brought by its sales representatives. [read post]
14 Feb 2012, 1:45 pm
Day in and day out, I look at internal documents from pharmaceutical companies. [read post]
14 Feb 2012, 1:45 pm
Day in and day out, I look at internal documents from pharmaceutical companies. [read post]